폐경기 여성의 호르몬 대치요법이 안구건조증상에 미치는 영향: 전향적 연구보고 = Effect of Hormone Replacement Therapy on Dry Eye Syndrome in Postmenopausal Women: A Prospective Study

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the effects of conjugated hormone replacement therapy (HRT) on dry eye syndrome in postmenopausal women. Methods: Thirty-six healthy postmenopausal women (72 eyes) were included in this three- month prospective study. Schirmer test, tear film break-up time (BUT), fluorescein staining score and symptom score were performed on all patients at the time of enrollment, one month and three months after initiation of HRT. All patients received HRT consisting of conjugated estrogen and progesterone taken orally in a continuous combined regimen. Results: Symptom score significantly decreased from 2.10±0.79 before HRT to 1.32±0.84 after one month and to 0.88±0.67 after three months (p＜0.001). In addition, tear film BUT measurements significantly increased from 6.04±2.54 seconds to 7.99±2.43 seconds after one month and to 8.93±2.20 after three months (p＜0.001). The fluorescein staining score was 0.94±0.71 before HRT and decreased to 0.42±0.60 after one month and to 0.22±0.42 after three months (p＜0.001). Conclusions: Hormone replacement therapy consisting of conjugated estrogen and progesterone significantly improved the symptoms and signs of dry eye syndrome in postmenopausal women. J Korean Ophthalmol Soc 2010;51(2):175-179

참고문헌 (Reference)

1 김성철, "폐경기 여성에서 호르몬 대치요법과 안구 건조 증상과의 관계" 대한안과학회 45 (45): 4-4, 2004

2 Vavilis D, "The effect of transdermal estradiol on the conjunctiva in postmenopausal women" 72 : 93-96, 1997

3 Pelit A, "Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women" 13 : 337-342, 2003

4 Lee HB, "Tear film break up time in normal Korean" 22 : 729-731, 1981

5 Nelson JD, "Sodium hyaluronate and polyvinyl alcohol artificial tear preparations" 106 : 484-487, 1988

6 Gamache DA, "Secretion of proinflammatory cytokines by human conjunctival epithelial cells" 5 : 117-128, 1997

7 Clinch TE, "Schimer test: a closer look" 101 : 1383-1386, 1983

8 Lemp MA, "Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes" 21 : 221-232, 1995

9 Chia EM, "Prevalence and associations of dry eye syndrome in an older population: The Blue Mountains Eye Study" 31 : 229-232, 2003

10 Evans V, "Menopause, hormone replacement therapy and tear function" 506 : 1029-1033, 2002

11 Wickham LA, "Identification of androgen, estrogen and progesterone receptor mRNAs in the eye" 78 : 146-153, 2000

12 Schaumberg DA, "Hormone replacement therapy and dry eye syndrome" 286 : 2114-2119, 2001

13 Farris RL, "Diagnostic test in keratoconjunctivitis sicca" 9 : 23-28, 1983

14 Kramer P, "Cyclic changes in conjunctival smears from menstruating females" 97 : 303-307, 1990

15 Guttridge NM, "Change in ocular and visual variables during the menstrual cycle" 14 : 38-48, 1994

16 Lucca JA, "A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, and tear osmolarity" 16 : 109-112, 1990